New Medicinal Marijuana Legislation Garners Favour and Criticism!


The issue of legalising medical marijuana has recently been brought up again in the state legislature.

Despite generating controversy and garnering some support, sponsors are continuing to push a law that would reverse several limits put in place only a year ago.

How and how much medicinal marijuana a patient can acquire at once are two of the issues the new bill seeks to address. What is best for the state is an issue of much debate.

Patients’ needs are not being met by Colorado’s medical cannabis programme. Advocates for Compassionate Therapy (ACT) Now’s Bridget Spirit characterised the current situation as a “community in crisis” due to the excessive regulation of the industry.

A law limiting the strength of THC was passed in 2021. As of January 1, 2018, those over the age of 21 are restricted to purchasing no more than eight grammes of medical marijuana concentrate each day. Seritt and other people who use marijuana for medical purposes have argued that the restrictions put in place by the law have left them helpless.

“We have parents now who are putting their kids at risk with child protective services because cannabis is the only therapy their kid responds to, but they can’t afford the card because it’s a thousand dollars now, or they can’t travel six hours to get to Denver or Boulder to get a recommendation. Seritt said that individuals in need of the programme would be disappointed since it is ineffective.

Legally, a patient must have a serious medical condition for which medicinal cannabis could be helpful, and their doctor must provide proof of that effect. In addition to the restrictions placed on those over the age of 21, those between the ages of 18 and 20 have their purchasing caps set at 2 grammes.

We need to protect our youngsters, especially when we are providing them medications that have addictive potential, and this bill’s implication that young people don’t need to have a real relationship with their physician and may instead undertake virtual visits is harmful.

The Executive Vice President of Smart Approaches to Marijuana (SAM), Luke Niforatos, said that this approach was the most logical, calling for marijuana to be regulated as a pharmaceutical.

Proponents of the bill argued that it would be a huge benefit for patients who cannot travel to see a doctor in person to have access to the remote access to doctors for medical marijuana that was used during the pandemic. Opponents argue that the bill is not really about expanding patient access.

Sales of both medical and recreational marijuana have significantly dropped. There was a lot of addiction and increased use during the pandemic, and I think it’s starting to revert back to more typical consumption levels now that the pandemic is over.

But I believe that the industry has the incentive to promote the free and open distribution of its products. And the motive behind this is monetary gain. The well-being of patients should be at the forefront of our minds as legislators and as a community, Niforatos emphasised.

Despite the bill’s introduction, its backers are still reluctant to discuss it publicly. They want to wait until they’ve made more headway on the legislation. If the legislation does not pass this session, its backers say they will continue to lobby for it next year, even if it means more users and parents may turn to the illegal market.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts